ReviewDrug design, development and therapy2026
Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug-Polymer Interactions to in vivo Performance.
Sucilawaty Ridwan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.